HOME › DRUGS › LEFAMULIN
ACTIVE SUBSTANCE / INN

LEFAMULIN

Brand name(s): Xenleta
EMA LISTED
AUTHORISED
Pneumonia, Bacterial;Community-Acquired Infections
ACTIVE SUBSTANCE
Lefamulin
REGULATORS
EMA
SPONSORS / MAH
Nabriva Therapeutics Ireland DAC
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
XenletaNabriva Therapeutics Ireland DACAuthorised27/07/2020Pneumonia, Bacterial;Community-Acquired Infections

FULL INTELLIGENCE ON LEFAMULIN

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →